Home > Research > Publications & Outputs > Catastrophic costs potentially averted by tuber...

Links

Text available via DOI:

View graph of relations

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. / Verguet, Stephane; Riumallo-Herl, Carlos; Gomez, Gabriela B. et al.
In: Lancet Global Health, Vol. 5, No. 11, 01.11.2017, p. E1123-E1132.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Verguet, S, Riumallo-Herl, C, Gomez, GB, Menzies, NA, Houben, RMGJ, Sumner, T, Lalli, M, White, RG, Salomon, JA, Cohen, T, Foster, N, Chatterjee, S, Sweeney, S, Baena, IG, Lonnroth, K, Weil, DE & Vassall, A 2017, 'Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study', Lancet Global Health, vol. 5, no. 11, pp. E1123-E1132. https://doi.org/10.1016/S2214-109X(17)30341-8

APA

Verguet, S., Riumallo-Herl, C., Gomez, G. B., Menzies, N. A., Houben, R. M. G. J., Sumner, T., Lalli, M., White, R. G., Salomon, J. A., Cohen, T., Foster, N., Chatterjee, S., Sweeney, S., Baena, I. G., Lonnroth, K., Weil, D. E., & Vassall, A. (2017). Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Lancet Global Health, 5(11), E1123-E1132. https://doi.org/10.1016/S2214-109X(17)30341-8

Vancouver

Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T et al. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Lancet Global Health. 2017 Nov 1;5(11):E1123-E1132. doi: 10.1016/S2214-109X(17)30341-8

Author

Verguet, Stephane ; Riumallo-Herl, Carlos ; Gomez, Gabriela B. et al. / Catastrophic costs potentially averted by tuberculosis control in India and South Africa : a modelling study. In: Lancet Global Health. 2017 ; Vol. 5, No. 11. pp. E1123-E1132.

Bibtex

@article{e31e9baf69fb4f7eb774bb4fb6cb778c,
title = "Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study",
abstract = "BackgroundThe economic burden on households affected by tuberculosis through costs to patients can be catastrophic. WHO's End TB Strategy recognises and aims to eliminate these potentially devastating economic effects. We assessed whether aggressive expansion of tuberculosis services might reduce catastrophic costs.MethodsWe estimated the reduction in tuberculosis-related catastrophic costs with an aggressive expansion of tuberculosis services in India and South Africa from 2016 to 2035, in line with the End TB Strategy. Using modelled incidence and mortality for tuberculosis and patient-incurred cost estimates, we investigated three intervention scenarios: improved treatment of drug-sensitive tuberculosis; improved treatment of multidrug-resistant tuberculosis; and expansion of access to tuberculosis care through intensified case finding (South Africa only). We defined tuberculosis-related catastrophic costs as the sum of direct medical, direct non-medical, and indirect costs to patients exceeding 20% of total annual household income. Intervention effects were quantified as changes in the number of households incurring catastrophic costs and were assessed by quintiles of household income.FindingsIn India and South Africa, improvements in treatment for drug-sensitive and multidrug-resistant tuberculosis could reduce the number of households incurring tuberculosis-related catastrophic costs by 6–19%. The benefits would be greatest for the poorest households. In South Africa, expanded access to care could decrease household tuberculosis-related catastrophic costs by 5–20%, but gains would be seen largely after 5–10 years.InterpretationAggressive expansion of tuberculosis services in India and South Africa could lessen, although not eliminate, the catastrophic financial burden on affected households.FundingBill & Melinda Gates Foundation.",
author = "Stephane Verguet and Carlos Riumallo-Herl and Gomez, {Gabriela B.} and Menzies, {Nicolas A.} and Houben, {Rein M. G. J.} and Tom Sumner and Marek Lalli and White, {Richard G.} and Salomon, {Joshua A.} and Ted Cohen and Nicola Foster and Susmita Chatterjee and Sedona Sweeney and Baena, {Ines Garcia} and Knut Lonnroth and Weil, {Diana E.} and Anna Vassall",
year = "2017",
month = nov,
day = "1",
doi = "10.1016/S2214-109X(17)30341-8",
language = "English",
volume = "5",
pages = "E1123--E1132",
journal = "Lancet Global Health",
issn = "2214-109X",
publisher = "Elsevier BV",
number = "11",

}

RIS

TY - JOUR

T1 - Catastrophic costs potentially averted by tuberculosis control in India and South Africa

T2 - a modelling study

AU - Verguet, Stephane

AU - Riumallo-Herl, Carlos

AU - Gomez, Gabriela B.

AU - Menzies, Nicolas A.

AU - Houben, Rein M. G. J.

AU - Sumner, Tom

AU - Lalli, Marek

AU - White, Richard G.

AU - Salomon, Joshua A.

AU - Cohen, Ted

AU - Foster, Nicola

AU - Chatterjee, Susmita

AU - Sweeney, Sedona

AU - Baena, Ines Garcia

AU - Lonnroth, Knut

AU - Weil, Diana E.

AU - Vassall, Anna

PY - 2017/11/1

Y1 - 2017/11/1

N2 - BackgroundThe economic burden on households affected by tuberculosis through costs to patients can be catastrophic. WHO's End TB Strategy recognises and aims to eliminate these potentially devastating economic effects. We assessed whether aggressive expansion of tuberculosis services might reduce catastrophic costs.MethodsWe estimated the reduction in tuberculosis-related catastrophic costs with an aggressive expansion of tuberculosis services in India and South Africa from 2016 to 2035, in line with the End TB Strategy. Using modelled incidence and mortality for tuberculosis and patient-incurred cost estimates, we investigated three intervention scenarios: improved treatment of drug-sensitive tuberculosis; improved treatment of multidrug-resistant tuberculosis; and expansion of access to tuberculosis care through intensified case finding (South Africa only). We defined tuberculosis-related catastrophic costs as the sum of direct medical, direct non-medical, and indirect costs to patients exceeding 20% of total annual household income. Intervention effects were quantified as changes in the number of households incurring catastrophic costs and were assessed by quintiles of household income.FindingsIn India and South Africa, improvements in treatment for drug-sensitive and multidrug-resistant tuberculosis could reduce the number of households incurring tuberculosis-related catastrophic costs by 6–19%. The benefits would be greatest for the poorest households. In South Africa, expanded access to care could decrease household tuberculosis-related catastrophic costs by 5–20%, but gains would be seen largely after 5–10 years.InterpretationAggressive expansion of tuberculosis services in India and South Africa could lessen, although not eliminate, the catastrophic financial burden on affected households.FundingBill & Melinda Gates Foundation.

AB - BackgroundThe economic burden on households affected by tuberculosis through costs to patients can be catastrophic. WHO's End TB Strategy recognises and aims to eliminate these potentially devastating economic effects. We assessed whether aggressive expansion of tuberculosis services might reduce catastrophic costs.MethodsWe estimated the reduction in tuberculosis-related catastrophic costs with an aggressive expansion of tuberculosis services in India and South Africa from 2016 to 2035, in line with the End TB Strategy. Using modelled incidence and mortality for tuberculosis and patient-incurred cost estimates, we investigated three intervention scenarios: improved treatment of drug-sensitive tuberculosis; improved treatment of multidrug-resistant tuberculosis; and expansion of access to tuberculosis care through intensified case finding (South Africa only). We defined tuberculosis-related catastrophic costs as the sum of direct medical, direct non-medical, and indirect costs to patients exceeding 20% of total annual household income. Intervention effects were quantified as changes in the number of households incurring catastrophic costs and were assessed by quintiles of household income.FindingsIn India and South Africa, improvements in treatment for drug-sensitive and multidrug-resistant tuberculosis could reduce the number of households incurring tuberculosis-related catastrophic costs by 6–19%. The benefits would be greatest for the poorest households. In South Africa, expanded access to care could decrease household tuberculosis-related catastrophic costs by 5–20%, but gains would be seen largely after 5–10 years.InterpretationAggressive expansion of tuberculosis services in India and South Africa could lessen, although not eliminate, the catastrophic financial burden on affected households.FundingBill & Melinda Gates Foundation.

U2 - 10.1016/S2214-109X(17)30341-8

DO - 10.1016/S2214-109X(17)30341-8

M3 - Journal article

VL - 5

SP - E1123-E1132

JO - Lancet Global Health

JF - Lancet Global Health

SN - 2214-109X

IS - 11

ER -